The effects of homocysteine and homocysteic acid on the metabotropic glutamate receptors of cerebellar neurons

被引:0
作者
I. A. Sergeeva
A. V. Makhro
A. N. Pegova
E. R. Bulygina
机构
[1] Moscow State University,Deparment of Biochemistry, Biological Faculty
[2] Russian Academy of Medical Sciences,Laboratory of Neurochemistry, Scientific Center of Neurology
来源
Neurochemical Journal | 2010年 / 4卷
关键词
homocysteine; metabotropic glutamate receptors; Na/K-ATPase;
D O I
暂无
中图分类号
学科分类号
摘要
Incubation of cerebellar neurons with homocysteine or homocysteic acid at a concentration of 500 μM for 30 min increases the intracellular level of free radicals. Specific antagonists of metabotropic glutamate receptors of the groups I (AIDA) and III (MSOP) decreased the accumulation of reactive oxygen species in cells, which suggests that homocysteine and homocysteic acid can interact with these receptors. Inhibition of NO-synthase does not affect the level of free radicals, which indicates that NO• did not contribute to an increase in the level of free radicals in neurons under our conditions. Neither homocysteine nor homocysteic acid induced neuronal death; however, both compounds inhibited neuronal Na/K-ATPase. Inhibition of Na/K-ATPase was stronger in the case of activation of ionotropic glutamate receptors by NMDA as compared to simultaneous activation of both ionotropic and metabotropic glutamate receptors by homocysteine or homocysteic acid.
引用
收藏
页码:116 / 121
页数:5
相关论文
共 59 条
  • [1] Seshadri S.(2002)undefined N. Engl. J. Med. 346 476-482
  • [2] Beiser A.(1997)undefined Proc. Natl. Acad. Sci. U.S.A. 94 5923-5928
  • [3] Selhub Y.(2006)undefined Neirokhimiya 23 1-8
  • [4] Lipton S.A.(2006)undefined Neirokhimiya 23 140-145
  • [5] Kim W.K.(2003)undefined Neu- rochem. Int. 43 481-492
  • [6] Choi Y.B.(1999)undefined J. Neurophysiol. 82 2820-2826
  • [7] Kumar S.(2003)undefined Exp. Neurol. 180 46-54
  • [8] D’Emilia D.M.(2001)undefined Neurochem. Res 26 1195-1200
  • [9] Rayuda P.V.(2002)undefined Neurochem. Res 27 1593-1598
  • [10] Arnell D.R.(2004)undefined J. Alzheimer Disease 4 6-324